Medical/Pharmaceuticals

AGC Biologics Partners with Faron Pharmaceuticals to Manufacture Cancer Treatment

AGC Biologics will manufacture novel precision cancer immunotherapy treatment Clevegen SEATTLE, May 5, 2020 /PRNewswire/ -- AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has been selected to commercially manufacture the treatment Clevegen f...

2020-05-05 20:30 2693

Antengene Announces Expansion of Partnership with Karyopharm in Asia Pacific Markets

SHANGHAI, May 5, 2020 /PRNewswire/ -- Antengene Corporation (Antengene) today announced a broadened partnership and territory expansion agreement with Karyopharm Therapeutics Inc. (NASDAQ: KPTI) (Karyopharm) for development and commercialization of four oral novel drugs and drug candidates to s...

2020-05-05 20:30 1996

Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership with CytoDyn for Drug Product Used in COVID-19 Clinical Trials

SAN DIEGO, May 5, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce it has entered into a manufacturing services agreement with CytoDyn Inc., a late stage biotechno...

2020-05-05 20:05 2241

Smith+Nephew partners with Fiagon for distribution of its ENT surgical navigation portfolio in Asia Pacific region

LONDON, May 5, 2020 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces an agreement with Fiagon – a technology leader in electromagnetic surgical navigation solutions – to distribute its ENT portfolio in theAsia Pacific region. This agreemen...

2020-05-05 08:00 11493

Tessa Therapeutics Announces New Executive Leadership

SINGAPORE, May 5, 2020 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments, today announced thatJeffrey H. Buchalter will assume the role of Chief Executive Officer, and Göran A. Ando will become Chairman of the Board, wi...

2020-05-05 00:00 2302

Ascentage Pharma's Core Drug Candidate HQP1351 Granted Orphan Drug Designation by the US FDA for the Treatment of Patients with Chronic Myeloid Leukemia

SUZHOU, China, and ROCKVILLE, Md., May 4, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug Adm...

2020-05-04 18:30 2072

Yiling Pharmaceutical to Increase Productivity of Lianhua Qingwen

SHIJIAZHUANG, China, May 4, 2020 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) announced to launch the productivity-improving project ofLianhua Qingwen, a traditional Chinese medicine (TCM) used mainly for the treatment of colds and viral influenza. The Company is set to produce 7.5 billion c...

2020-05-04 08:15 4532

MGH Flies SpiceJet Charters Ensuring India's Supply Chain Amidst COVID-19 Pandemic

GURGAON, India, May 3, 2020 /PRNewswire/ -- SpiceJet's fleet of five dedicated freighters are crisscrossing the global skies carrying vital supplies including medicines, medical devices, cold-chain medical supplies, farm produce for various governments, medical and pharma companies, retailers and...

2020-05-03 10:00 3874

Venus Medtech and Opus Medical Therapies, LLC Announce Partnership for Transcatheter Mitral Valve Replacement (TMVR) and Transcatheter Tricuspid Valve Replacement (TTVR) in Greater China Market

HANGZHOU, China and ATLANTA, May 2, 2020 /PRNewswire/ -- Venus Medtech (Hangzhou ) Inc. ("Venus Medtech" or the "Company", together with its subsidiaries, the "Group", stock code: 2500), the leading Chinese transcatheter heart valve company and Opus Medical Therapies, LLC, a medical device company...

2020-05-02 16:54 7298

Reminder: Deadline To File Claims In The Purdue Pharma L.P. Bankruptcy Is June 30, 2020

NEW YORK, May 2, 2020 /PRNewswire/ -- The following is being issued by Prime Clerk, the court-appointed claims and noticing agent. This is a reminder that Tuesday, June 30, 2020, at 5:00 p.m. (Prevailing Eastern Time) is the deadline or bar date for filing claims in the bankruptcy of Purdue Phar...

2020-05-02 01:19 3372

Trio Pharmaceuticals, Inc. and Ajinomoto Bio-Pharma Services Enter into a Development Collaboration for a Novel Antibody Therapeutic

SAN DIEGO and SAN FRANCISCO, April 30, 2020 /PRNewswire/ -- Trio Pharmaceuticals, Inc. ("TRIO"), a cancer therapeutics company developing novel dual action antibody drugs, TRIObody™, and novel dual action antibody drug conjugates, TRIObody Drug Conjugate™ (TDC™) and Ajinomoto Bio-Pharma Services ...

2020-04-30 20:05 2653

Data From Merck at ASCO 2020 to Showcase Significant Clinical Advances in Cancer Care

- Not intended for US-, Canada- or UK-based media - ASCO Abstract # BAVENCIO® (avelumab): LBA1, 5061; Bintrafusp alfa (bifunctional fusion protein):9558; Tepotinib (MET kinase inhibitor): 9556, 9575.   - Late-breaking presentation of Phase III JAVELIN Bladder 100 data for BAVENCIO® showing over...

2020-04-30 20:00 2873

INOVIO Expands Manufacturing of COVID-19 DNA Vaccine INO-4800 With New Funding from CEPI

INOVIO and Richter-Helm BioLogics will expand existing DNA manufacturing agreement to support large-scale manufacturing of INO-4800 INO-4800 Phase 2/3 U.S. clinical trial being prepared to start this summer PLYMOUTH MEETING, Pennsylvania, April 30, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO) today ...

2020-04-30 20:00 3812

CPhI & P-MEC China to host 'Virtual Expo Connect' in June

SHANGHAI, April 30, 2020 /PRNewswire/ -- CPhI and P-MEC China -- co-organized by Informa Markets, CCCMHPIE and Sinoexpo Informa Markets -- will host a special Virtual Expo Connect in June (18-24, 2020). The new online platform is designed to facilitate ongoing and new business connections in an a...

2020-04-30 19:13 4598

WuXi Biologics and Aravive Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies Targeting Cancer and Fibrosis Using the WuXiBody™ Platform

SHANGHAI and HOUSTON, April 30, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, and Aravive, Inc. (NASDAQ:ARAV), a clinical-stage biopharmaceutical company, today announced a strategic collaboration agreement...

2020-04-30 19:00 1925

Frost & Sullivan Presents the Unprecedented Opportunities in the Personal Protection Equipment Industry

Upcoming webinar will provide insight on how the PPE industry is reassessing supply chain strategies due to the COVID-19-related surge from the healthcare industry SANTA CLARA, California, April 29, 2020 /PRNewswire/ -- The COVID-19 pandemic has caught the world by surprise, and a shortage of pe...

2020-04-29 23:00 2630

Mindray Launches New Portable Ultrasound Systems ME Series to Combat COVID-19

#SeeBeyondBorders ME Series Online Global Launch Event (LIVE) Apr. 29 | 20:30 (CST), 14:30 (CEST), 8:30 (EDT) SHENZHEN, China, April 29, 2020 /PRNewswire/ -- Mindray Medical (SZSE: 300760), a leading global provider of medical devices and solutions, announces ...

2020-04-29 20:30 9120

LimaCorporate Announces the Successful Completion of the First Total Shoulder Replacement Using the Smart SPACE 3D Positioner

SAN DANIELE DEL FRIULI, Italy, April 29, 2020 /PRNewswire/ -- LimaCorporate continues to make progresses on its key strategic initiative to drive the development of a digital platform to provide surgeons with innovative solutions which would help them deliver improved outcomes with an accessible ...

2020-04-29 20:00 2448

HeiQ Calls for Textile Industry's United Effort by Offering Proprietary "Viroblock" to CHT, JINTEX and Piedmont

ZURICH, April 29, 2020 /PRNewswire/ -- Swiss textile innovator HeiQ  announces that it offers proprietary formulation technologyHeiQ Viroblock NPJ03 to its peers, calling for a united effort to help fight the global pandemic. Striving to help advance the global fight agains...

2020-04-29 19:00 4373

SEASUN BIOMATERIALS to launch COVID-19 Rapid Molecular Assay

SEOUL, South Korea, April 29, 2020 /PRNewswire/ -- SEASUN BIOMATERIALS announced on that they will release their second COVID-19 assay "AQ-TOP COVID-19 Rapid Detection Kit" on 1 May, just after the completion of FDA EUA (April-27) of their U-TOP COVID-19 Real-Time Detection Kit.

2020-04-29 08:00 5169
1 ... 368369370371372373374 ... 396